tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
AMLX
Amylyx Pharmaceuticals Inc
RESEARCH TOOLSreports
Want to see AMLX full AI Analyst Report?

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

659 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q4 2025), Amylyx Pharmaceuticals Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Amylyx Pharmaceuticals Inc's net income was $-33.00M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 87.37M$ 380.79M$ 22.23M$ 0.00
Gross Profit
$ -525.00K$ 45.22M$ 355.35M$ 19.24M$ 0.00
Operating Expenses
$ 152.77M$ 359.95M$ 316.54M$ 220.58M$ 82.69M
Depreciation and Amortization
$ 525.00K$ 904.00K$ 1.09M$ 487.00K$ 52.00K
EBITDA
$ -144.16M$ -290.98M$ 39.89M$ -200.85M$ -82.64M
Operating Income
$ -153.29M$ -314.73M$ 38.80M$ -201.34M$ -82.69M
Other Income/Expenses
$ 8.60M$ 12.60M$ 15.49M$ 3.74M$ -5.24M
Pretax Income
$ -144.69M$ -302.14M$ 54.30M$ -197.60M$ -87.93M
Net Income
$ -144.74M$ -301.74M$ 49.27M$ -198.38M$ -87.93M
Per Share Metrics
Basic EPS
$ -1.53$ -4.43$ 0.73$ -2.98$ -1.52
Diluted EPS
$ -1.53$ -4.43$ 0.70$ -2.98$ -1.52
Weighted Average Shares Outstanding
 94.57M 68.14M 67.23M 66.51M 57.86M
Weighted Average Shares Outstanding (Diluted)
 94.57M 68.14M 69.99M 66.51M 57.86M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History